1. High glucose abolishes the antiproliferative effect of 17[beta]-estradiol in human vascular smooth muscle cells
- Author
-
Ling, Shanhong, Little, Peter J., Williams, Maro R.I., Dai, Aozhi, Hashimura, Kazuhiko, Liu, Jun-Ping, Komesaroff, Paul A., and Sudhir, Krishnankutty
- Subjects
Physiology -- Research ,Estradiol -- Physiological aspects ,Smooth muscle -- Physiological aspects ,Cell proliferation -- Research ,Estrogen -- Physiological aspects ,Protein kinases -- Physiological aspects ,Biological sciences - Abstract
We examined effects of 17[beta]-estradiol ([E.sub.2]) on human vascular smooth muscle cell (VSMC) proliferation under normal (5 mmol/l) and high (25 mmol/l) glucose concentrations. Platelet-derived growth factor (PDGF) BB (20 ng/ml)-induced increases in DNA synthesis and proliferation were greater in high than normal glucose concentrations; the difference in DNA synthesis was abolished by a protein kinase C (PKC)-[beta] inhibitor, LY-379196 (30 nmol/l). Western blotting showed that PKC-[[beta].sub.1] protein increased in cells exposed to high glucose, whereas PKC-[alpha] protein and total PKC activity remained unchanged, compared with normal glucose cultures. In normal glucose, [E.sub.2] (1-100 nmol/l) inhibited PDGF-induced DNA synthesis by 18-37% and cell proliferation by 16-22% in a concentration-dependent manner. The effects of [E.sub.2] were blocked by the estrogen receptor (ER) antagonist ICI-182780, indicating ER dependence. In high glucose, the inhibitory effect of [E.sub.2] on VSMC proliferation was abolished but was restored in the presence of the PKC-[beta] inhibitor LY-379196. Thus high glucose enhances human VSMC proliferation and attenuates the antiproliferative effect of [E.sub.2] in VSMC via activation of PKC-[beta]. high glucose; estrogen; proliferation; smooth muscle cells; protein kinase C-[beta]
- Published
- 2002